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were examined using the immunohistocemistry of the mouse limb
cartilage. Cell proliferation was assessed by PCNA staining. For gain-
and loss-of-function analyses, genes or the speciﬁc siRNAs were
overexpressed in ATDC5 cells with stable retroviral transfection or
in primary chondrocytes with adenoviral transfection. Transcriptional
regulation was examined by luciferase assay using ATDC5 and non-
chondrogenic HeLa cells transfected with a reporter construct containing
a promoter fragment of the differentiation marker genes above.
Transactivity of b-catenin was determined by the TOPﬂash system.
Computational predictions were performed using the online resource
NetworKIN for in vivo kinase-substrate relationships, and the GEO
database for expressions in the growth plate cartilage.
Results: Both isoforms were largely unphosphorylated and active in
the early differentiation stages of chondrocytes in cultured ATDC5
cells and in the mouse limb cartilage. Although Gsk3a−/− mice and
Gsk3b+/− mice showed normal skeletal development, their compound
Gsk3a−/−;Gsk3b+/− mice exhibited dwarﬁsm with impairment of early
chondrocyte differentiation without affecting the later differentiation
or proliferation. Gain- and loss-of-function analyses using cultures
of ATDC5 cells and primary chondrocytes from the knockout mice
with overexpression of GSK-3 isoforms and their siRNAs revealed
that GSK-3a and GSK-3b induced early chondrocyte differentiation
with functional redundancy in a cell-autonomous fashion. This was
independent of the canonical Wnt signaling, since the transcriptional
activity of b-catenin was not altered by the Gsk3 genotypes. Instead,
computational predictions followed by SOX9 and COL2A1 promoter assays
identiﬁed RelA (NF-úB p65) as a key phosphorylation target of GSK-3.
Further analyses by mutagenesis in the 12 putative phosphorylation
sites of RelA revealed that the Thr254-phosphorylation was essential for
GSK-3 to induce chondrocyte differentiation. The Cre-mediated deletion
of RelA in the Relaﬂ/ﬂ chondrocyte culture caused suppression of the early
differentiation markers, which was restored by the RelA overexpression,
but not by the Thr254 mutant or the GSK-3 overexpression. Lastly,
we created conditional knockout mice of Rela in undifferentiated limb
mesenchyme (Prx1-Cre;Relaﬂ/ﬂ) and in cartilage (Col2a1-Cre;Relaﬂ/ﬂ), and
conﬁrmed that both mouse models exhibited dwarﬁsm with impairment
of early chondrocyte differentiation, similar to the Gsk3a−/−;Gsk3b+/−
mice.
Conclusions: This study is the ﬁrst to show in vivo evidence of
the functional relationship of GSK-3a and GSK-3b through analysis of
compound knockout mice. Redundant functions of the two isoforms
through phosphorylation of RelA at Thr254 play a crucial role in early
stages of chondrocyte differentiation.
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Purpose: In osteoarthritis (OA), articular chondrocytes undergo
phenotypic change and acquire the ability to over-express matrix-
degrading genes. We previously showed that DNA methylation at CpG
sites in the relevant promoters is correlated with the aberrant expression
of several genes, includingMMP13. However, how CpGmethylation status
intervenes to determine the promoter activity of genes such as MMP13
is still not known. The aims of the study were to determine (1) whether
CpG methylation directly affects MMP13 promoter activities, (2) which
CpG sites are responsible for changes in MMP13 promoter responses and
(3) what transcription factors are involved in CpG methylation-related
promoter regulation of MMP13.
Methods: The methylation status of the MMP13 proximal promoter and
the MMP13 gene expression were quantiﬁed in healthy and OA human
primary chondrocytes by pyrosequencing and RT-qPCR, respectively.
Three MMP13 reporter constructs, spanning −372/+14, −214/+14 and
−86/+14 bp of the proximal human MMP13 promoter were generated
by PCR-ampliﬁcation and cloned into a CpG-free luciferase reporter
vector. CpG-mutant constructs were generated by substituting CG to TG
using the wild-type −214/+14 MMP13 construct as template. Luciferase
activities were quantiﬁed for each reporter construct, untreated or
treated with DNA methyltransferase (M.SssI), and transfected in human
immortalized C28/I2 chondrocytes, alone or in co-transfection with
expression vectors encoding HIF1-alpha, HIF2-alpha, ESE1, cFos, cJun,
Runx2, USF1, GATA1 or Sp1. Chromatin immunoprecipitation (ChIP)
assays were performed in C28/I2 cells in co-transfection experiments
utilizing non-methylated or methylated MMP13 constructs, and HIF2-
alpha expression vectors, and analyzed by qPCR utilizing speciﬁc PCR
primers for the transiently transfected MMP13 constructs.
Results: The aberrant MMP13 gene expression in human primary
OA chondrocytes (25-fold higher compared to non-OA chondrocytes)
correlated with increased DNA demethylation of the MMP13 proximal
promoter, with the CpG site at −110 bp showing the greater percentage
of demethylation from the seven CpG sites contained within the −330/−14
bp proximal sequence. Luciferase assays revealed that methylation of the
wild-type MMP13 reporter constructs lead to a signiﬁcant decrease on
their basal activities. Mutation of different proximal CpG sites indicated
that only the mutation at the −110bp-CpG was able to repress the
basal activity of the non-methylated MMP13 promoter. In agreement,
the MMP13 promoter activity was preserved in a mutant construct
in which all the proximal CpG sites except for −110bp were mutated,
and methylation treatment repressed the activity of the same reporter
construct.. Over-expression of different transcription factors indicated
that only the HIF2-alpha-driven MMP13 transactivation was affected by
CpG methylation at −110bp, correlating with the decreased HIF2-alpha
binding to the methylated MMP13 proximal promoter in ChIP assays.
Conclusions: We here show that CpG methylation directly represses
the MMP13 promoter activity in vitro, and that the methylation status
of the −110bp CpG site is critical for the promoter activity, leading to
its decreased basal and HIF2-alpha-driven activity, and reducing the
binding of HIF2-alpha to the proximal promoter. The latter indicates that
HIF2-alpha shows less afﬁnity to its methylated DNA binding site, and
suggests that HIF2-alpha is likely to be a potential target of epigenetic
transcriptional regulation of MMP13.
Fig. 1. CpG methylation alters the HIF2-alpha-driven MMP13 promoter
transactivation. (a) Single CpG mutation. (b) Triple CpG mutation leaving
only one CpG intact (*p< 0.05; **p < 0.01; ***p < 0.001).
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Purpose: There is an increasing body of evidence that inﬂammatory
T cells from the synovium have a major role in the progression of
osteoarthritis by overproduction of cytokines and growth factors. The
balance between inﬂammatory and regulatory T cells is considered
to play an important role in this process. Mesenchymal stromal cells
have been extensively investigated for their tissue regeneration potential
through the last two decades. More recently, interest has partially focused
on immunogenic properties of MSC, and their abilities to regulate T-cell
and especially regulatory T-cell (Treg) function. However, their role
in regulation of immunity in arthritic diseases, most importantly in
osteoarthritis, remains mostly unknown. The purpose of this study was
to determine the inﬂuence of mesenchymal stromal cells (MSC) from
osteoarthritis (OA) patients on regulation and recruitment of regulatory
T-cells.
Methods: Bone marrow (BM) and synovial membrane (SM) was
harvested from OA patients during total hip arthroplasty (n = 19).
MSC were isolated from BM and SM and cultured in DMEM-LG
until P2. Functional analysis and immunophenotyping conﬁrmed the
presence of typical MSC markers. Mixed lymphocyte cultures enriched
in CD4+CD25+CD127− regulatory T-cells (Treg+MLC) were derived from
whole blood taken from healthy donors. Treg+MLC and MSC were
